Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(27 sites)
United States
UT Southwestern Medical Centre, Dallas, Texas Australia
Westmead Hospital, Sydney, New South Wales St George Hospital, Sydney, New South Wales The Prince Charles Hospital, Brisbane, Queensland Princess Alexandra Hospital, Brisbane, Queensland St Andrew's War Memorial Hospital, Brisbane, Queensland Royal Adelaide Hospital, Adelaide, South Australia Flinders Medical Centre, Adelaide, South Australia Flinders Private, Adelaide, South Australia Royal Hobart Hospital, Hobart, Tasmania The Alfred Hospital, Melbourne, Victoria The Royal Melbourne Hospital, Melbourne, Victoria Austin Health, Melbourne, Victoria Epworth HealthCare, Melbourne, Victoria Cabrini Health, Melbourne, Victoria Victorian Heart Hospital, Melbourne, Victoria Sir Charles Gairdner, Nedlands, Western Australia St John of God Subiaco Hospital, Perth, Western Australia Fiona Stanley Hospital, Perth, Western Australia St Vincent's Hospital, Melbourne Canada
Halifax Infirmary, Halifax, Nova Scotia New Zealand
Christchurch Hospital, Christchurch Waikato Hospital, Hamilton Wakefield Hospital, Wellington Wellington Hospital, Wellington